BullFrog AI Holdings, Inc. BFRG
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2023-02-14
BullFrog AI Holdings, Inc. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $116,670 | — | $65,000 | $10,000 | — |
| Gross profit | $21,892 | — | $59,800 | $9,200 | — |
| R&D expense | $1.8M | $2.2M | $1.4M | $609,270 | $25,000 |
| Operating income | -$6.6M | -$7.2M | -$5.4M | -$2.5M | -$555,362 |
| Interest expense | — | — | $79,089 | $347,145 | $40,395 |
| Net income | -$6.5M | -$7.0M | -$5.4M | -$2.8M | -$585,840 |
| EPS (diluted) | $-0.63 | $-0.85 | $-0.89 | $-0.70 | — |
| Operating cash flow | -$5.5M | -$5.6M | -$6.0M | -$910,890 | -$382,405 |
| Free cash flow | — | — | — | -$919,634 | — |
| Cash & equivalents | $2.2M | $5.4M | $2.6M | $57,670 | — |
| Total assets | $2.8M | $5.6M | $2.8M | $80,369 | $10,014 |
| Total liabilities | $672,022 | $588,090 | $184,350 | $3.1M | $1.0M |
| Shareholders' equity | $2.1M | $5.0M | $2.6M | -$3.1M | -$1.0M |
Source: SEC EDGAR filings · CIK 0001829247 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.